Literature DB >> 1497896

Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons.

G A Cohen1, V A Doze, D V Madison.   

Abstract

Opiates and the opioid peptide enkephalin can cause indirect excitation of principal cortical neurons by reducing inhibitory synaptic transmission mediated by GABAergic interneurons. The mechanism by which opioids mediate these effects on interneurons is unknown, but enkephalin hyperpolarizes the somatic membrane potential of a variety of neurons in the brain, including hippocampal interneurons. We now report a new, more direct mechanism for the opioid-mediated reduction in synaptic inhibition. The enkephalin analog D-Ala2-Met5-enkephalinamide (DALA) decreases the frequency of miniature, action potential-independent, spontaneous GABAergic inhibitory postsynaptic currents (IPSCs) without causing a change in their amplitude. Thus, we conclude that DALA inhibits the action potential-independent release of GABA through a direct action on interneuronal synaptic terminals. In contrast, DALA reduces the amplitude of action potential-evoked, GABA-mediated IPSCs, as well as decreases their frequency. This suggests that the opioid-mediated inhibition of non-action potential-dependent GABA release reveals a mechanism that contributes to reducing action potential-evoked GABA release, thereby decreasing synaptic inhibition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1497896     DOI: 10.1016/0896-6273(92)90171-9

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  60 in total

1.  Opioids suppress IPSCs in neurons of the rat medial septum/diagonal band of Broca: involvement of mu-opioid receptors and septohippocampal GABAergic neurons.

Authors:  M Alreja; M Shanabrough; W Liu; C Leranth
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

2.  Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons.

Authors:  J T Kittler; P Delmas; J N Jovanovic; D A Brown; T G Smart; S J Moss
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

3.  Desensitization of mu-opioid receptor-evoked potassium currents: initiation at the receptor, expression at the effector.

Authors:  Christophe Blanchet; Christian Lüscher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

4.  A role of actin filament in synaptic transmission and long-term potentiation.

Authors:  C H Kim; J E Lisman
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

5.  Delta opioid receptors colocalize with corticotropin releasing factor in hippocampal interneurons.

Authors:  T J Williams; T A Milner
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

6.  Silent GABAA synapses during flurazepam withdrawal are region-specific in the hippocampal formation.

Authors:  P Poisbeau; S R Williams; I Mody
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

7.  Kappa-opioid receptor activation modulates Ca2+ currents and secretion in isolated neuroendocrine nerve terminals.

Authors:  K I Rusin; D R Giovannucci; E L Stuenkel; H C Moises
Journal:  J Neurosci       Date:  1997-09-01       Impact factor: 6.167

8.  Synchronous GABA-mediated potentials and epileptiform discharges in the rat limbic system in vitro.

Authors:  M Avoli; M Barbarosie; A Lücke; T Nagao; V Lopantsev; R Köhling
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

9.  The influences of reproductive status and acute stress on the levels of phosphorylated delta opioid receptor immunoreactivity in rat hippocampus.

Authors:  Suzanne R Burstein; Tanya J Williams; Diane A Lane; Margarete G Knudsen; Virginia M Pickel; Bruce S McEwen; Elizabeth M Waters; Teresa A Milner
Journal:  Brain Res       Date:  2013-04-11       Impact factor: 3.252

10.  Mechanism of mu-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in vitro.

Authors:  M Capogna; B H Gähwiler; S M Thompson
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.